Characterization of genomic alterations of cytarabine-resistant AML cells with FLT3-ITD mutation

被引:0
|
作者
Yen, J. H. [1 ]
Chen, Z. A. [2 ]
Lin, L. I. [3 ]
Chen, P. Y. [4 ]
机构
[1] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan
[2] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan
[3] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan
[4] Hualien Tzu Chi Hosp, Ctr Med Genet, Hualien, Taiwan
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P13.06B
引用
收藏
页码:1608 / 1608
页数:1
相关论文
共 50 条
  • [41] Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation
    Bogdanov, Konstantin
    Kudryavtseva, Ekaterina
    Fomicheva, Yulia
    Churkina, Irina
    Lomaia, Elza
    Girshova, Larisa
    Osipov, Yuri
    Zaritskey, Andrey
    PATHOPHYSIOLOGY, 2023, 30 (03) : 296 - 313
  • [42] Temporal Acquisition of FLT3-ITD or RAS Mutation at Transformation to AML from MDS: Clinical Implications
    Badar, Talha
    Thompson, Philip A.
    George, Binsah
    Daver, Naval
    Borthakur, Gautam
    Cortes, Jorge E.
    Konopleva, Marina
    Kadia, Tapan M.
    Bohannan, Zach
    Pierce, Sherry
    Jabbour, Elias
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Patel, Keyur P.
    Luthra, Raja
    Sukholutsky, Victoria
    Manero, Guillermo Garcia
    BLOOD, 2014, 124 (21)
  • [43] Influence of IDH on FLT3-ITD status in newly diagnosed AML
    P Boddu
    K Takahashi
    N Pemmaraju
    N Daver
    C B Benton
    S Pierce
    M Konopleva
    F Ravandi
    J Cortes
    H Kantarjian
    C D DiNardo
    Leukemia, 2017, 31 : 2526 - 2529
  • [44] ASXL1-Mutated Donor HSCs Evolved into FLT3-ITD Positive AML in the Unrelated Donor and FLT3-ITD Negative AML in the Recipient after Transplant
    Liu, Zhongwen
    Liu, Hongxing
    Zhang, Yanli
    Kong, Dai
    Shi, Jie
    Zhang, Yin
    Wen, Meiying
    Song, Yongping
    Tong, Chunrong
    Chen, Mingyi
    Murphy, William J.
    Sun, Kai
    BLOOD, 2015, 126 (23)
  • [45] Dual Inhibition of AKT/FLT3-ITD by A674563 Overcomes FLT3 Ligand-Induced Drug Resistance in FLT3-ITD positive AML
    Wang, Aoli
    Wu, Hong
    Chen, Cheng
    Hu, Chen
    Qi, Ziping
    Wang, Wenchao
    Yu, Kailin
    Liu, Xiaochuan
    Zou, Fengming
    Zhao, Zheng
    Wu, Jiaxin
    Liu, Juan
    Liu, Feiyang
    Wang, Li
    Stone, Richard M.
    Galinksy, Ilene A.
    Griffin, James D.
    Zhang, Shanchun
    Weisberg, Ellen L.
    Liu, Jing
    Liu, Qingsong
    ONCOTARGET, 2016, 7 (20) : 29131 - 29142
  • [46] The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cells
    Hospital, Marie-Anne
    Green, Alexa S.
    Lacombe, Catherine
    Mayeux, Patrick
    Bouscary, Didier
    Tamburini, Jerome
    BLOOD, 2012, 119 (07) : 1791 - 1792
  • [47] Role of HDAC8 Upregulation in Resistance of FLT3-ITD AML Stem Cells to FLT3 Inhibitors
    Long, Jun
    Jia, Mingyuan
    Fang, Weiyue
    Chen, Xinjie
    Wang, Zhongyu
    Mu, Lili
    Xiang, Rufang
    Li, Jun-Min
    Hong, Dengli
    Liang, Aibin
    Hu, Jiong
    BLOOD, 2019, 134
  • [48] Pediatric AML with FLT3-ITD Treated with Gilteritinib: A Report of Two Cases
    Uemura, Yuta
    Meguro, Toru
    Kanno, Miyako
    Sato, Hiroko
    Kawasaki, Motoi
    Kawasaki, Naomi
    Ishigaki, Ryusuke
    Matsuuchi, Shoko
    Muranaka, Akari
    Mitsui, Tetsuo
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [49] Cigarette smoke exposure accelerates AML progression in FLT3-ITD models
    Figueroa, Mary
    Ma, Huaxian
    Alfayez, Mansour
    Morales-Mantilla, Daniel Enrique
    Wang, Fei
    Lu, Yue
    Estecio, Marcos R.
    King, Katherine Y.
    Kleinerman, Eugenie
    Moghaddam, Seyed Javad
    Daver, Naval
    Andreeff, Michael
    Konopleva, Marina
    Dinardo, Courtney
    Chandra, Joya
    BLOOD ADVANCES, 2023, 7 (21) : 6624 - 6629
  • [50] Relapse Mechanism of FLT3-ITD Positive AML and Cell Differentiation Blockage
    Hayun, Michal
    Zaatra, Maria
    Itzkovitch, Chen
    Sahar, Dvora
    Dann, Eldad J.
    Louria-Hayon, Igal
    Ofran, Yishai
    BLOOD, 2015, 126 (23)